These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6928402)

  • 1. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
    Catapano MS; Brown JM; Rosenberg SA
    Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
    Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
    Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
    Roth JA; Wesley RA
    Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fetal antigens by normal human skin cells grown in tissue culture.
    Thorpe WP; Parker GA; Rosenberg SA
    J Immunol; 1977 Sep; 119(3):818-23. PubMed ID: 330754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral immunity in human sarcomas].
    Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
    Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
    Brown JM
    Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological significance of human melanoma cytotoxic antibody.
    Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
    Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface antigens on equine sarcoid cells and normal dermal fibroblasts as assessed by xenogeneic antisera.
    Brostroöm H; Paulie S; Perlmann P
    Res Vet Sci; 1989 Mar; 46(2):172-9. PubMed ID: 2704881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of specific serologic reactivity in human osteosarcoma.
    Sindelar WF
    Cancer; 1983 Feb; 51(3):444-51. PubMed ID: 6185204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts.
    Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA
    Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxicity in progressive systemic sclerosis: no evidence for increased cytotoxicity against fibroblasts of different origin.
    Cooper SM; Friou GJ
    J Rheumatol; 1979; 6(1):25-9. PubMed ID: 439107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of sarcomas.
    Mitchell MS
    Clin Orthop Relat Res; 1980; (153):26-30. PubMed ID: 6160937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-beta activity.
    Akudugu JM; Bell RS; Catton C; Davis AM; Griffin AM; O'Sullivan B; Waldron JN; Ferguson PC; Wunder JS; Hill RP
    Radiother Oncol; 2006 Jan; 78(1):17-26. PubMed ID: 16380182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of macrophage mediated cytotoxicity: role of target cell sialic acid.
    Cameron DJ; Churchill WH
    Jpn J Exp Med; 1982 Feb; 52(1):9-16. PubMed ID: 6957642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonogenic survival and cytokinesis-blocked binucleation of skin fibroblasts and normal tissue complications in soft tissue sarcoma patients treated with preoperative radiotherapy.
    Akudugu JM; Bell RS; Catton C; Davis AM; O'Sullivan B; Waldron J; Wunder JS; Hill RP
    Radiother Oncol; 2004 Jul; 72(1):103-12. PubMed ID: 15236882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.